Company: MVNC
Filing Date: 2025-04-25
Form Type: 10-K
Source: 0001683168-25-002807
Chunk: 11

Company: Marvion Inc.
Filing Date: 2025-04-25
Form: 10-K
Item: Item 12
Chunk 11
---
 common stock, stock appreciation rights, restricted stock units, dividend equivalents,
performance awards or other stock-based awards. As of the date of this Annual Report, the Company issued the balance of 31,430,316 shares remaining under the
Plan for an aggregate total of 37,075,060 shares issued under the Plan.

Registration with the Securities and Exchange
Commission

17,000,000,000
shares of common stock reserved for issuance under the Plan were registered on Form S-8 with the Securities and Exchange Commission (the
“SEC”) on September 21, 2023. Effective April 23, 2024, the Company effectuated a reverse stock
split whereby each three thousand (3,000) shares of Common Stock issued and outstanding prior to the effective time were combined and
converted into one (1) shares of Common Stock. As a result, the number of shares reserved for issuance under the 2023 Plan was equitably
reduced to 5,666,667. On December 28, 2024, the Board approved an amendment to the 2023 Plan to increase the number of shares
available for issuance under the Plan to an aggregate of 37,075,060 shares. A registration statement on Form S-8 covering these additional
shares was filed with the SEC on February 11, 2025.

ITEM 13.
  Certain Relationships and Related Transactions, and Director Independence. 

Other
than as disclosed below, there are no transactions during our two most recent fiscal years ended December 31, 2024, and December 31, 2023,
or any currently proposed transaction, in which our Company was or to be a participant and the amount exceeds the lesser of $120,000 or
one percent of the average of our Company’s total assets at year end for our last two completed years, and in which any of our directors,
officers or principal stockholders, or any other related person as defined in Item 404 of Regulation S-K, had or have any direct or indirect
material interest.

From
time to time, the following related parties advanced funds to the Company for capital expenditures and working capital purpose:

    Name of related parties
     
    Relationship
     
    December 31, 2024
     
    December 31, 2023

    Chan Sze Yu
     
    Director
     
    $1,088,838
     
    $1,020,409

    Young